OmniAb (OABI) Research & Development (2022 - 2026)

OmniAb's (OABI) quarterly Research & Development came in at $9.6 million in Q1 2026, down 23.5% year-on-year from $12.6 million in Q1 2025, and down 30.69% on a QoQ basis from $13.9 million in Q4 2025.

OmniAb (OABI) Research & Development (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of Research & Development data on file, last reported at $9.6 million in Q1 2026.

  • On a quarterly basis, Research & Development fell 23.5% year-over-year to $9.6 million in Q1 2026; TTM through Mar 2026 was $44.8 million, a 15.74% decrease from a year earlier, with the FY2025 full-year figure at $47.8 million, down 13.35% from the prior year.
  • Research & Development for Q1 2026 stood at $9.6 million, down from $13.9 million in the prior quarter.
  • Over the last five years, Research & Development for OABI reached as high as $14.8 million in Q4 2023 and fell as low as $9.6 million in Q1 2026.
  • Historically, Research & Development has averaged $12.8 million across 5 years, with a median of $13.3 million in 2024.
  • Across the five-year window, Research & Development rose 27.73% in 2023 and slipped 23.5% in 2026, its largest moves.
  • Year by year, Research & Development stood at $12.9 million in 2022, then rose by 14.3% to $14.8 million in 2023, then decreased by 9.89% to $13.3 million in 2024, then increased by 4.53% to $13.9 million in 2025, then sank by 30.69% to $9.6 million in 2026.
  • Per Business Quant data, the three most recent Research & Development figures were $9.6 million in Q1 2026, $13.9 million in Q4 2025, and $10.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -17.94 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 1.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 541.22 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 15.66 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -443.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 343.97 Mn
10 OmniAb 263.54 Mn 214.47 Mn 14.41 Mn 9.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 9.64 Mn
Dec 31, 2025 13.91 Mn
Sep 30, 2025 10.38 Mn
Jun 30, 2025 10.86 Mn
Mar 31, 2025 12.60 Mn
Dec 31, 2024 13.31 Mn
Sep 30, 2024 13.32 Mn
Jun 30, 2024 13.94 Mn
Mar 31, 2024 14.55 Mn
Dec 31, 2023 14.77 Mn
Sep 30, 2023 13.87 Mn
Jun 30, 2023 14.13 Mn
Mar 31, 2023 13.76 Mn
Dec 31, 2022 12.92 Mn
Sep 30, 2022 13.19 Mn
Jun 30, 2022 11.48 Mn
Mar 31, 2022 10.77 Mn